Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 51

Sort by

Sort Order Select

Journal Articles

Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis

Frits R. Rosendaal, Roberta Palla, Isabella Garagiola, Pier M. Mannucci, Flora Peyvandi

Blood (2017) 130 (15): 1757–1759.

https://doi.org/10.1182/blood-2017-06-791756

Published: 2017

Includes: Supplemental data

Journal Articles

New concepts for anticoagulant therapy in persons with hemophilia

Roger E. G. Schutgens, Jeroen F. van der Heijden, Eveline P. Mauser-Bunschoten, Pier M. Mannucci

Blood (2016) 128 (20): 2471–2474.

https://doi.org/10.1182/blood-2016-07-727032

Published: 2016

Journal Articles

Alloantibodies in von Willebrand disease

Paula D. James, David Lillicrap, Pier M. Mannucci

Blood (2013) 122 (5): 636–640.

https://doi.org/10.1182/blood-2012-10-462085

Published: 2013

Journal Articles

A Randomized, Double-Blind, Placebo-Controlled, Clinical Outcome Study of ARC1779 In Patients with Thrombotic Thrombocytopenic Purpura (TTP)

Spero R Cataland, MD, Flora Peyvandi, MD, PhD, Pier M. Mannucci, MD, Bernhard Lämmle, Johanna A Kremer Hovinga, MD, Samuel J Machin, Marie Scully, Gail Rock, PhD, MD, FRCP, James Gilbert, MD, Paul Knoebl, Shangbin Yang, PhD, Haifeng Wu, M.D., Bernd Jilma, MD

Blood (2010) 116 (21): 726.

https://doi.org/10.1182/blood.V116.21.726.726

Published: 2010

Journal Articles

Transient Elastography (Fibroscan ® ) In Adult Patients with Inherited Bleeding Disorders and Chronic Hepatitis C.

Maria Elisa Mancuso, MD, PhD, Alessio Aghemo, MD, Paolo Bucciarelli, MD, Elena Santagostino, MD, PhD, Mariagrazia Rumi, MD, Massimo Colombo, MD, Pier M. Mannucci, MD

Blood (2010) 116 (21): 1413.

https://doi.org/10.1182/blood.V116.21.1413.1413

Published: 2010

Journal Articles

A Two-Year Prospective Study on Bleeding Tendency In 105 Patients with Type 2 A and M Von Willebrand Disease

Giancarlo Castaman, MD, Augusto B. Federici, MD, Luciano Baronciani, Pier M. Mannucci, MD, Francesco Rodeghiero

Blood (2010) 116 (21): 543.

https://doi.org/10.1182/blood.V116.21.543.543

Published: 2010

Journal Articles

Recombinant Human Von Willebrand Factor (rhVWF): First-In-Human Study Evaluating Pharmacokinetics, Demonstrating Safety and Tolerability In Type 3 Von Willebrand Disease

Tobias Suiter, MD, Michael Laffan, DM, FRCP, FRCPath, Pier M. Mannucci, MD, Christine L. Kempton, MD, MSc, Edward H Romond, MD, Amy D. Shapiro, MD, Ingvild Birschmann, MD, PhD, Joan Cox Gill, MD, Margaret V. Ragni, MD, MPH, Peter Turecek, PhD, Bruce M. Ewenstein, MD, PhD, VrWF Study Team Baxter BioScience

Blood (2010) 116 (21): 237.

https://doi.org/10.1182/blood.V116.21.237.237

Published: 2010

Journal Articles

How I treat age-related morbidities in elderly persons with hemophilia

Pier M. Mannucci, Roger E. G. Schutgens, Elena Santagostino, Evelien P. Mauser-Bunschoten

Blood (2009) 114 (26): 5256–5263.

https://doi.org/10.1182/blood-2009-07-215665

Published: 2009

Journal Articles

Response: Comparing joint arthroplasties in severe hemophilia A with severe hemophilia B

Giuseppe Tagariello, Alfonso Iorio, Pier M. Mannucci

Blood (2009) 114 (23): 4907–4908.

https://doi.org/10.1182/blood-2009-09-244566

Published: 2009

Journal Articles

Prevalence and Determinants of Bleeding in Severe Von Willebrand Disease Type 3: Results of Retro/Prospective Studies in a Cohort of 105/52 Italian Patients.

Augusto B. Federici, Paolo Bucciarelli, MD, Alfonso Iorio, Giancarlo Castaman, Maria Gabriella Mazzucconi, Massimo Morfini, Angiola Rocino, MD, Pier M. Mannucci, MD

Blood (2009) 114 (22): 3494.

https://doi.org/10.1182/blood.V114.22.3494.3494

Published: 2009

Journal Articles

Circulating Microparticles and Risk of Venous Thromboembolism.

Paolo Bucciarelli, MD, Emanuele Previtali, MD, Ida Martinelli, MD, PhD, Andrea Artoni, MD, Serena M Passamonti, MD, Giuliana Merati, BSc, Armando Tripodi, BSc, Pier M. Mannucci, MD

Blood (2009) 114 (22): 3987.

https://doi.org/10.1182/blood.V114.22.3987.3987

Published: 2009

Journal Articles

Response: Anticoagulation in splanchnic vein thrombosis

Ida Martinelli, Massimo Franchini, Massimo Primignani, Pier M. Mannucci

Blood (2009) 113 (20): 5032.

https://doi.org/10.1182/blood-2009-03-203778

Published: 2009

Journal Articles

Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients

Augusto B. Federici, Pier M. Mannucci, Giancarlo Castaman, Luciano Baronciani, Paolo Bucciarelli, Maria T. Canciani, Alessandro Pecci, Peter J. Lenting, Philip G. De Groot

Blood (2009) 113 (3): 526–534.

https://doi.org/10.1182/blood-2008-04-152280

Published: 2009

Journal Articles

Von Willebrand Factor-Glycoprotein Ib-Alpha Interactions Play a Role in Generating Platelet Microparticles: Data from Ex Vivo and in Vitro Studies

Andrea Artoni, MD, Anna Lecchi, MariaElisa Mancuso, MD, Elena Santagostino, MD, Augusto Federici, MD, Pier M. Mannucci, MD

Blood (2008) 112 (11): 3920.

https://doi.org/10.1182/blood.V112.11.3920.3920

Published: 2008

Journal Articles

Factor V Leiden Is Associated with Premature Myocardial Infarction.

Flora Peyvandi, Marta Spreafico, Luisa Foco, Luisa Bernardinelli, Stefano Duga, Rosanna Asselta, Diego Ardissino, Sekar Kathiresan, Pierangelica Merlini, Pier M. Mannucci, MD

Blood (2008) 112 (11): 1817.

https://doi.org/10.1182/blood.V112.11.1817.1817

Published: 2008

Journal Articles

A Poor Response to Desmopressin Is Observed in Patients with Mild Hemophilia a and No Detectable FVIII Mutation.

Giancarlo Castaman, Sofia Giacomelli, Elena Santagostino, Alberto Tosetto, MariaElisa Mancuso, Pier M. Mannucci, Francesco Rodeghiero

Blood (2008) 112 (11): 3383.

https://doi.org/10.1182/blood.V112.11.3383.3383

Published: 2008

Journal Articles

Relevance of Chloride Binding to Von Willebrand Factor in Type 2B Von Willebrand Disease Patients.

Luciano Baronciani, PhD, Flora Peyvandi, MD, Margherita Punzo, PhD, Maria T. Canciani, PhD, Enrico Di Stasio, MD, Augusto B. Federici, MD, Pier M. Mannucci, MD, Raimondo De Cristofaro, MD

Blood (2008) 112 (11): 3384.

https://doi.org/10.1182/blood.V112.11.3384.3384

Published: 2008

Journal Articles

Pharmacokinetic Evaluation of a Fibrinogen Concentrate in Patients with Congenital Fibrinogen Deficiency.

Marilyn J. Manco-Johnson, MD, Giancarlo Castaman, MD, Sandra Fremann, MD, Sigurd Knaub, PhD, Gavino Piseddu, MD, Pier M. Mannucci, MD

Blood (2008) 112 (11): 2268.

https://doi.org/10.1182/blood.V112.11.2268.2268

Published: 2008

Journal Articles

Circulating Versus Progenitor Endothelial Cells Levels Are Abnormal in Patients with Different Types of Von Willebrand Disease and Correlate with Markers of Angiogenesis

Giuseppe Gritti, MD, Augusto B Federici, MD, Agostino Cortelezzi, MD, Luciano Baronciani, PhD, Silvia Lonati, PhD, Margherita Punzo, Ilaria Silvestris, Rosanna Garavaglia, MD, Giorgio Lambertenghi, MD, Pier M Mannucci, MD

Blood (2008) 112 (11): 5457.

https://doi.org/10.1182/blood.V112.11.5457.5457

Published: 2008

Journal Articles

Increased Thrombin Generation in Severe Hemophiliacs with Mild Clinical Phenotype

Elena Santagostino, Maria Elisa Mancuso, Armando Tripodi, Veena Chantarangkul, Gianluigi Pasta, Simona Maria Siboni, Pier M. Mannucci, MD

Blood (2008) 112 (11): 515.

https://doi.org/10.1182/blood.V112.11.515.515

Published: 2008

NARROW

Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis

New concepts for anticoagulant therapy in persons with hemophilia

Alloantibodies in von Willebrand disease

A Randomized, Double-Blind, Placebo-Controlled, Clinical Outcome Study of ARC1779 In Patients with Thrombotic Thrombocytopenic Purpura (TTP)

Transient Elastography (Fibroscan ® ) In Adult Patients with Inherited Bleeding Disorders and Chronic Hepatitis C.

A Two-Year Prospective Study on Bleeding Tendency In 105 Patients with Type 2 A and M Von Willebrand Disease

Recombinant Human Von Willebrand Factor (rhVWF): First-In-Human Study Evaluating Pharmacokinetics, Demonstrating Safety and Tolerability In Type 3 Von Willebrand Disease

How I treat age-related morbidities in elderly persons with hemophilia

Response: Comparing joint arthroplasties in severe hemophilia A with severe hemophilia B

Prevalence and Determinants of Bleeding in Severe Von Willebrand Disease Type 3: Results of Retro/Prospective Studies in a Cohort of 105/52 Italian Patients.

Circulating Microparticles and Risk of Venous Thromboembolism.

Response: Anticoagulation in splanchnic vein thrombosis

Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients

Von Willebrand Factor-Glycoprotein Ib-Alpha Interactions Play a Role in Generating Platelet Microparticles: Data from Ex Vivo and in Vitro Studies

Factor V Leiden Is Associated with Premature Myocardial Infarction.

A Poor Response to Desmopressin Is Observed in Patients with Mild Hemophilia a and No Detectable FVIII Mutation.

Relevance of Chloride Binding to Von Willebrand Factor in Type 2B Von Willebrand Disease Patients.

Pharmacokinetic Evaluation of a Fibrinogen Concentrate in Patients with Congenital Fibrinogen Deficiency.

Circulating Versus Progenitor Endothelial Cells Levels Are Abnormal in Patients with Different Types of Von Willebrand Disease and Correlate with Markers of Angiogenesis

Increased Thrombin Generation in Severe Hemophiliacs with Mild Clinical Phenotype

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only